Microba Life Sciences Ltd
ASX:MAP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.07
0.315
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MAP stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.071 AUD, Microba Life Sciences Ltd is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Microba Life Sciences Ltd
MAP looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if MAP is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Microba Life Sciences Ltd.
| US |
|
CVS Health Corp
NYSE:CVS
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
|
| US |
|
Cigna Corp
NYSE:CI
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Microba Life Sciences Ltd
Balance Sheet Decomposition
Microba Life Sciences Ltd
| Current Assets | 19m |
| Cash & Short-Term Investments | 10.9m |
| Receivables | 4.1m |
| Other Current Assets | 4m |
| Non-Current Assets | 28.4m |
| PP&E | 3.9m |
| Intangibles | 24.6m |
| Other Non-Current Assets | -100 |
| Current Liabilities | 10.2m |
| Accounts Payable | 4.3m |
| Accrued Liabilities | 2.2m |
| Other Current Liabilities | 3.7m |
| Non-Current Liabilities | 4.8m |
| Long-Term Debt | 1.5m |
| Other Non-Current Liabilities | 3.3m |
Free Cash Flow Analysis
Microba Life Sciences Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Microba Life Sciences Ltd
|
Revenue
|
15.7m
AUD
|
|
Cost of Revenue
|
-8.2m
AUD
|
|
Gross Profit
|
7.4m
AUD
|
|
Operating Expenses
|
-27.3m
AUD
|
|
Operating Income
|
-19.8m
AUD
|
|
Other Expenses
|
4.9m
AUD
|
|
Net Income
|
-14.9m
AUD
|
MAP Profitability Score
Profitability Due Diligence
Microba Life Sciences Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Microba Life Sciences Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
MAP Solvency Score
Solvency Due Diligence
Microba Life Sciences Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Microba Life Sciences Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MAP Price Targets Summary
Microba Life Sciences Ltd
According to Wall Street analysts, the average 1-year price target for MAP is 0.219 AUD with a low forecast of 0.141 AUD and a high forecast of 0.305 AUD.
Dividends
Current shareholder yield for MAP is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one MAP stock under the Base Case scenario is hidden AUD.
Compared to the current market price of 0.071 AUD, Microba Life Sciences Ltd is hidden .